Pharmacokinetics sentence example

pharmacokinetics
  • These changes in pharmacokinetics do not necessitate dosage adjustment.
    0
    0
  • Food intake therefore has no significant effect on the pharmacokinetics of propiverine hydrochloride modified release capsules.
    0
    0
  • Pantoprazole: Co-administration of pantoprazole (80 mg od) did not alter the pharmacokinetics of cinacalcet.
    0
    0
  • Smoking cessation with or without nicotine replacement may alter the pharmacokinetics of certain concomitant medicines.
    0
    0
  • Corticosteroids do not appear to affect the pharmacokinetics of infliximab to a clinically relevant extent.
    0
    0
    Advertisement
  • The authors set out to identify whether levetiracetam, the newest of the anti-epileptic drugs, influences the pharmacokinetics of steroid oral contraceptives.
    0
    0
  • Data are insufficient to draw conclusions regarding pharmacokinetics in moderate hepatic impairment.
    0
    0
  • Topiramate exhibits linear pharmacokinetics with low levels of protein binding.
    0
    0
  • pharmacokinetics over the dose range of 10 to 600 mg.
    0
    0
  • Analytical expertise also supports experimental and clinical pharmacokinetics, including support for clinical trials involving new drugs at Mount Vernon Hospital and elsewhere.
    0
    0
    Advertisement
  • Patients with poor renal function may require dosage adjustments due to altered pharmacokinetics of carboplatin.
    0
    0
  • A population pharmacokinetics analysis was conducted on samples from over 1,100 MS patients receiving doses ranging from 3 to 6 mg/kg natalizumab.
    0
    0
  • Neurontin steady-state pharmacokinetics are similar for healthy subjects and patients with epilepsy receiving anti-epileptic agents.
    0
    0
  • Discuss the influence of clinical characteristics on drug pharmacokinetics.
    0
    0
  • This linearity is support for dose -independent pharmacokinetics of digoxin in man.
    0
    0
    Advertisement
  • pharmacokinetics in elderly patients with epilepsy.
    0
    0
  • pharmacokinetics of new anti-epileptic drugs (AEDs ).
    0
    0
  • pharmacokinetics of atazanavir.
    0
    0
  • pharmacokinetics of cinacalcet does not change over time.
    0
    0
  • pharmacokinetics of aripiprazole.
    0
    0
    Advertisement
  • pharmacokinetics of darbepoetin alfa has been studied clinically in chronic renal failure patients following intravenous and subcutaneous administration.
    0
    0
  • pharmacokinetics of ibandronic acid was not assessed in patients with end-stage renal disease managed by other than haemodialysis.
    0
    0
  • The pharmacokinetics of insulin lispro protamine suspension are consistent with those of an intermediate-acting insulin, such as NPH.
    0
    0
  • saturable pharmacokinetics and a strong tendency to accumulate.
    0
    0
  • Thiopentone has saturable pharmacokinetics and a strong tendency to accumulate.
    0
    0
    Advertisement
  • "The pharmacokinetics of antiviral therapy in pediatric patients."
    0
    0
  • Dutta, S., et al. "Divalproex-ER pharmacokinetics in older children and adolescents."
    0
    0
  • Stempak, D., et al. "Single-dose and steady-state pharmacokinetics of celecoxib in children."
    0
    0